Canopy Going Forward?There are currently over 300 Licenced Producers in Canada, for cultivators, processors, sales, etc. Some LP's have multiple licences included in the over 300, like Tweed, which has 3 (page 30):
https://www.canada.ca/en/health-canada/services/drugs-medication/cannabis/industry-licensees-applicants/licensed-cultivators-processors-sellers.html#wb-auto-5
If you look at the major producers (or were major producers), most are running out of cash and their stock values are, or are, near penny stocks:
CannTrust - no longer is a LP so most medical users going to Canopy
Aurora - slowly going out of business, done within 6 months (stock below $1.00)
Hexo - going out of business (had $5/gram pot as their big seller)
Tilray - slowly going out business, remember was $300 USD, now less than $3, lost 99% value
Aphria - will likely survivie, but will have to scale back operations (especially globally)
Cronos, OGI, VFF, CURA all slowly running out of cash, especialy when no one is lending to the pot sector.
As David Klein said yesterday on BNN, they have $2.3 Billion in cash and are scaling back operations to reduce cash outflow. So now Canopy will dominate in Canada on the rec., medical and edibles. But more importantly, they will be able to grow their global operations with little competition. Klein has said that there are no plans to currently scale back operations, especially in Europe and UK.
As for the US, that's a dog's breakfast and anything positive going forward is gravy for Canopy because they will have no Canadian competition going in to the US. Trump may get desperate to beat Biden and try to approve the SAFE Banking and States Acts. GLTA